Modulation of the Human Microbiome: Probiotics, Prebiotics, and Microbial Transplants
- PMID: 40111698
- DOI: 10.1007/978-3-031-79146-8_17
Modulation of the Human Microbiome: Probiotics, Prebiotics, and Microbial Transplants
Abstract
The balance between health and disease is intrinsically linked to the interactions between microbial communities and the host. This complex environment of antagonism and synergy involves both prokaryotic and eukaryotic cells, whose collaborative metabolic pathways and immunomodulatory elements influence system homeostasis. As with the gut and other niches, the oral microbiome has the capacity to affect distal host sites. The ability to manipulate this environment holds the potential to impact local and systemic disease.With the increasing threat of antimicrobial resistance, novel approaches to reduce the burden of disease are essential. The use of probiotics and prebiotics is one such strategy. Probiotics introduce non-pathogenic bacteria into the environment to compete with pathogens for nutrients and attachment sites, or to produce metabolites that counteract disease aetiologies. Prebiotic compounds enhance the growth of health-associated organisms, offering additional benefits, whilst a conjunctive approach with probiotics potentially holds even greater promise. Though widely studied in the gastrointestinal context, their potential for treating oral diseases, such as dental caries and periodontitis, is less understood. Additionally, the use of microbial transplantations has demonstrated efficacy in other areas, reducing systemic inflammation and recolonising with commensal bacteria. Here we evaluate their use in the oral context and their modulatory impact on overall health.In this chapter, we discuss how pro- and prebiotic strategies seek to modulate both the oral and gut environments to promote oral health and prevent disease. We assess novel approaches for utilising health-associated microorganisms to combat oral disorders, either administered locally in the mouth or imparting influence through immune modulation via the oral-gut axis. By examining available clinical trial data, we aim to further understand the intricacies involved in this discipline. Furthermore, we consider the challenges facing the research community, including optimal candidate organism/compound selection and colonisation retention, as well as considerations for future research.
Keywords: Caries; Microbial transplantation; Microbiome; Oral–gut axis; Periodontal disease; Prebiotics; Probiotics.
© 2025. The Author(s), under exclusive license to Springer Nature Switzerland AG.
References
-
- Alforaidi S, Bresin A, Almosa NA, Lehrkinder A, Lingström P (2020) Oral colonisation after the administration of drops containing Lactobacillus reuteri. Oral Health Prev Dent 18(1):1017–1023 - PubMed
-
- Amargianitakis M, Antoniadou M, Rahiotis C, Varzakas T (2021) Probiotics, prebiotics, synbiotics and dental caries. New perspectives, suggestions, and patient coaching approach for a cavity-free mouth. Appl Sci [Internet] 11(12):5472
-
- Argandoña Valdez RM, La X-F, Caiaffa KS, Rodrigues dos Santos V, Gonzales Cervantes RM, Almaguer-Flores A et al (2021) Antagonist effect of probiotic bifidobacteria on biofilms of pathogens associated with periodontal disease. Microb Pathog 150:104657 - PubMed
-
- Arimatsu K, Yamada H, Miyazawa H, Minagawa T, Nakajima M, Ryder MI et al (2014) Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep 4(1):1–9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
